350 filings
Page 5 of 18
8-K
cga 340sl39rb
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
FWP
5hca41s5rfjq5 wweig
17 Dec 19
Free writing prospectus
12:00am
8-K
pawje p2lugjqa7
13 Dec 19
NanoViricides President Dr. Anil Diwan Provides Responses to Shareholder Questions at the Annual Meeting of Shareholders
5:19pm
UPLOAD
yh8ft2 xdad5
9 Dec 19
Letter from SEC
12:00am
NT 10-Q
s11r17rzvj
14 Nov 19
Notice of late quarterly filing
1:55pm
8-K
h63dcx9gbfbinm 8qp
5 Nov 19
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
9:39pm
RW
tll5i2t oxu1lwy90r
5 Nov 19
Registration withdrawal request
9:32pm
S-1
i88b h4ydwh56tk0hx
28 Sep 19
IPO registration
3:07am
8-K
pkwlfzg864ikjm
26 Sep 19
Amendments to Articles of Incorporation or Bylaws
6:02am
8-K
z07c17 whzwv
1 Aug 19
Departure of Directors or Certain Officers
4:30pm
8-K
irblkz5
10 Jun 19
Departure of Directors or Certain Officers
6:02am
D
gr1vlykj
8 Mar 19
$2.5M in equity / options, sold $2.5M, 2 investors
3:33pm
8-K
w00hfesu08gk3ire3r00
1 Mar 19
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
6:11am